Drug Shortage Report for TARO-ATORVASTATIN
| Report ID | 202113 |
| Drug Identification Number | 02313758 |
| Brand name | TARO-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 90 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-10 |
| Estimated end date | 2025-01-17 |
| Actual end date | 2025-01-22 |
| Shortage status | Resolved |
| Updated date | 2025-01-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.